Oncology
Overview
Oncology is the branch of medicine dedicated to the diagnosis, treatment, and study of cancer. It involves managing various types of tumors, both malignant and benign, and includes therapies such as chemotherapy, radiation, immunotherapy, and targeted therapies. Oncologists work to understand cancer biology, develop new treatments, and provide comprehensive care to improve outcomes and quality of life for cancer patients.
Overview
Name
Oncology
Journals
483
Journals
Recent Articles
1.
Danielli L, Tassinari E, Marchetti A, Rosellini M, Mollica V, Cheng L, et al.
Expert Rev Anticancer Ther
. 2025 Mar;
PMID: 40089934
Introduction: Prostate cancer represents a significant oncological challenge, with its natural history predominantly driven by androgen receptor (AR) signaling. The pivotal role of this pathway underscores the rationale for targeting...
2.
Fines C, McCarthy H, Buckley N
Cancer Biol Ther
. 2025 Mar;
26(1):2472432.
PMID: 40089851
Nearly 20 million people are diagnosed with cancer each year with breast cancer being the most common among women. Triple negative breast cancer (TNBC), defined by its no/low expression of...
3.
Cirne F, Sedelaar M, Narayan V, Macedo A, Koo C, de Jesus J, et al.
Cardiooncology
. 2025 Mar;
11(1):28.
PMID: 40089789
Advances in the diagnosis and management of prostate cancer have significantly changed the disease landscape. While benefiting from better oncological outcomes, patients are now experiencing higher rates of non-cancer comorbidities,...
4.
Dai J, Lu X, Zhang C, Qu T, Li W, Su J, et al.
Mol Cancer
. 2025 Mar;
24(1):79.
PMID: 40089784
Background: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC). However, patients inevitably develop acquired drug resistance, resulting in recurrence or...
5.
6.
Yoshida T, Rogers C, Raza J, Matsuda T, Kinoshita H
Ann Surg Oncol
. 2025 Mar;
PMID: 40089618
No abstract available.
7.
de Moraes F, de Castro Ribeiro C, Pessoa F, Chaves J, de Souza A, Di Felipe Avila Alcantara D, et al.
Breast Cancer Res
. 2025 Mar;
27(1):39.
PMID: 40089780
Background: Currently, the primary methods for detecting HER2 expression levels are immunohistochemistry (IHC) and in situ hybridization (ISH), with the traditional standard being a HER2-positive score of 3 + accompanied...
8.
Kuerban S, Chen H, Chen L, Zhang L, Li X, Zhen B, et al.
World J Surg Oncol
. 2025 Mar;
23(1):90.
PMID: 40089765
Background: A blood-based approach to monitor metastasis and recurrence of esophageal squamous cell carcinoma (ESCC) remains undeveloped. This study aimed to establish a dependable model utilizing cfDNA 5-hydroxymethylcytosines (5hmC) signatures...
9.
Bhatia D, Dolcetti R, Mazzieri R
J Exp Clin Cancer Res
. 2025 Mar;
44(1):98.
PMID: 40089746
In the last two decades, novel and promising cell-based therapies have populated the treatment landscape for haematological tumors. However, commonly exploited T and NK cell-based therapies show limited applicability to...
10.
Zhou N, Bai H, Zhang Z, Yu B, Zhao H, Li J, et al.
BMC Cancer
. 2025 Mar;
25(1):481.
PMID: 40089733
Background: Identifying the past and future burden of kidney cancer (KC) and its temporal trends among older adults (≥ 65 years) at global, regional, and national levels is critical for...